The assessment discusses fifty eight peptides in numerous clinical phases, indicating a strong pipeline of peptide therapies targeting PPIs. Clinical trials and preclinical studies are highlighted, demonstrating the efficacy of peptide vaccines in inducing an immune response, with the prospective to improve survival rates for HCC people. Simi